Lonza Group AG (LZAGF)
OTCMKTS · Delayed Price · Currency is USD
693.00
+5.79 (0.84%)
Aug 14, 2025, 9:38 AM EDT
Model N Market Cap
Lonza Group AG has a market cap or net worth of $48.36 billion as of August 14, 2025. Its market cap has increased by 5.23% in one year.
Market Cap
48.36B
Enterprise Value
53.03B
Revenue
8.92B
Ranking
n/a
PE Ratio
52.46
Stock Price
$693.00
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 3.78B to 48.36B, an increase of 1,179.47%. That is a compound annual growth rate of 10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 48.36B | 13.34% |
| Dec 30, 2024 | 42.67B | 36.74% |
| Dec 29, 2023 | 31.20B | -14.17% |
| Dec 30, 2022 | 36.35B | -41.26% |
| Dec 30, 2021 | 61.89B | 29.41% |
| Dec 30, 2020 | 47.82B | 76.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 300.87M |